Days on ventilator · adult patients after liver transplantation.
1 finding from 1 review
Mortality [within first 10 weeks after liver transplantation] · adult patients after liver transplantation.
Parenteral nutrition plus branched‐chain‐amino‐acid‐enriched formula showed no clear difference in mortality [within first 10 weeks after liver transplantation] compared with standard isotonic intravenous glucose solution (low certainty).
1 finding from 1 review
Length of hospital stay after liver transplantation [days] · adult patients after liver transplantation.
2 findings from 1 review
Days on ventilator · adult patients after liver transplantation.
1 finding from 1 review
Length of hospital stay after liver transplantation [days] · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Mortality [within first 10 weeks after liver transplantation] · adult patients after liver transplantation.
Standard parenteral nutrition may leads to lower mortality [within first 10 weeks after liver transplantation] compared with standard isotonic intravenous glucose solution (low certainty).
1 finding from 1 review
Length of hospital stay after liver transplantation [days] · adult patients after liver transplantation.
1 finding from 1 review
Intensive care unit length of stay after liver transplantation [days] (ITT) · adult patients after liver transplantation.
1 finding from 1 review
Acute rejection · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with omega‐3 fish oil changes acute rejection episodes compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
All‐cause mortality · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with omega‐3 fish oil changes mortality compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
Hepatic encephalopathy related hospitalisation · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Changes in grade of hepatic encephalopathy [grade 0‐4] · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Re‐hospitalisation post liver transplantation [event per patient] · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Infections [event per patient] · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Sustained virological response · participants with detectable HCV RNA after 12 weeks of treatment with pegylated interferon and ribavirin, but with >= 2 log viral…
It is very uncertain whether extended peginterferon plus ribavirin treatment for 72 weeks changes sustained virological response (SVR) compared with standard peginterferon plus ribavirin treatment (very low certainty).
1 finding from 1 review
Relapse · participants with detectable HCV RNA after 12 weeks of treatment with pegylated interferon and ribavirin, but with >= 2 log viral…
It is very uncertain whether extended peginterferon plus ribavirin treatment for 72 weeks changes relapse compared with standard peginterferon plus ribavirin treatment (very low certainty).
1 finding from 1 review
End of treatment response (ETR) · participants with detectable HCV RNA after 12 weeks of treatment with pegylated interferon and ribavirin, but with >= 2 log viral…
It is very uncertain whether extended peginterferon plus ribavirin treatment for 72 weeks changes end of treatment response (ETR) compared with standard peginterferon plus ribavirin treatment (very low certainty).
1 finding from 1 review
Sustained virological response · participants with detectable HCV RNA after four weeks of treatment with pegylated interferon and ribavirin
Extended peginterferon plus ribavirin treatment for 72 weeks may leads to higher sustained virological response (SVR) compared with standard peginterferon plus ribavirin treatment (low certainty).
1 finding from 1 review
Relapse · participants with detectable HCV RNA after four weeks of treatment with pegylated interferon and ribavirin
Extended peginterferon plus ribavirin treatment for 72 weeks may leads to lower relapse rate compared with standard peginterferon plus ribavirin treatment (low certainty).
1 finding from 1 review
End of treatment response (ETR) · participants with detectable HCV RNA after four weeks of treatment with pegylated interferon and ribavirin
Extended peginterferon plus ribavirin treatment for 72 weeks may leads to lower end of treatment response (ETR) compared with standard peginterferon plus ribavirin treatment (low certainty).
1 finding from 1 review